Abstract
The in vitro activity of thienamycin was compared to that of other antibiotics against a large panel of bacteria obtained in blood cultures from cancer patients. This compound was the most active against gram-positive cocci and also proved to be extremely active against the gram-negative bacteria. It was also very active against multi-resistant gram-negative bacilli. Because of its broad spectrum of activity including Pseudomonas spp., thienamycin deserves clinical testing in the future.
Original language | English (US) |
---|---|
Pages (from-to) | 50-52 |
Number of pages | 3 |
Journal | Infection |
Volume | 10 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 1982 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases